Joseph Fomusi Ndisang Selected Research

heme arginate

7/2015	Heme Oxygenase Improves Renal Function by Potentiating Podocyte-Associated Proteins in Nω-Nitro-l-Arginine-Methyl Ester (l-NAME)-Induced Hypertension.
7/2014	Heme oxygenase suppresses markers of heart failure and ameliorates cardiomyopathy in L-NAME-induced hypertension.
12/2012	Treatment with heme arginate alleviates adipose tissue inflammation and improves insulin sensitivity and glucose metabolism in a rat model of Human primary aldosteronism.
7/2010	Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
4/2010	Heme-arginate suppresses phospholipase C and oxidative stress in the mesenteric arterioles of mineralcorticoid-induced hypertensive rats.
7/2009	Heme arginate suppresses cardiac lesions and hypertrophy in deoxycorticosterone acetate-salt hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph Fomusi Ndisang Research Topics

Disease

16	Inflammation (Inflammations) 01/2017 - 06/2008
13	Hypertension (High Blood Pressure) 07/2015 - 09/2002
13	Insulin Resistance 01/2014 - 04/2009
11	Fibrosis (Cirrhosis) 07/2015 - 06/2008
10	Hypertrophy 01/2015 - 11/2008
10	Hyperglycemia 01/2014 - 04/2009
8	Proteinuria 01/2018 - 03/2009
8	Albuminuria 01/2018 - 03/2009
6	Obesity 01/2014 - 01/2010
5	Necrosis 01/2016 - 04/2009
5	Cardiomegaly (Heart Hypertrophy) 05/2013 - 11/2008
5	Hyperaldosteronism (Conn Syndrome) 12/2012 - 06/2008
4	Essential Hypertension 01/2014 - 06/2008
3	Cicatrix (Scar) 09/2009 - 11/2008
2	Atrophy 07/2015 - 01/2014
2	Heart Failure 07/2014 - 01/2013
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2014 - 04/2009
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2014 - 01/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2013 - 02/2010
2	Edema (Dropsy) 01/2010 - 04/2009
2	Body Weight (Weight, Body) 09/2009 - 11/2008
2	Type 2 Diabetes Mellitus (MODY) 05/2009 - 05/2009
1	Atherosclerosis 12/2016
1	Rhabdomyolysis 01/2015
1	Cystic Kidney Diseases (Cystic Kidney Disease) 01/2015
1	Hypertriglyceridemia 01/2015
1	Renal Insufficiency (Renal Failure) 01/2015
1	Nephritis 01/2015
1	Sepsis (Septicemia) 01/2015
1	Acute Kidney Injury (Acute Renal Failure) 01/2015
1	Cardiomyopathies (Cardiomyopathy) 07/2014
1	Kidney Diseases (Kidney Disease) 01/2014

Drug/Important Bio-Agent (IBA)

27	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2016 - 05/2003
19	Hemin (Panhematin)FDA Link 01/2015 - 06/2008
17	Proteins (Proteins, Gene)FDA Link 07/2015 - 11/2008
13	Insulin (Novolin)FDA Link 01/2014 - 04/2009
12	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 04/2009
10	AdiponectinIBA 07/2015 - 04/2009
9	Fibronectins (Fibronectin)IBA 07/2015 - 11/2008
9	NF-kappa B (NF-kB)IBA 01/2014 - 06/2008
8	CollagenIBA 07/2015 - 11/2008
8	Acetates (Acetic Acid Esters)FDA Link 01/2015 - 06/2008
8	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2015 - 06/2008
6	AntioxidantsIBA 01/2017 - 11/2008
6	heme arginateIBA 07/2015 - 07/2009
6	CreatinineIBA 07/2015 - 03/2009
6	AldosteroneIBA 07/2014 - 01/2007
6	Ferritins (Ferritin)IBA 01/2014 - 03/2009
6	SaltsIBA 12/2012 - 06/2008
6	Desoxycorticosterone Acetate (DOCA)FDA Link 12/2012 - 06/2008
5	Atrial Natriuretic Factor (ANF)IBA 07/2015 - 07/2010
5	Carbon MonoxideIBA 01/2014 - 05/2003
5	chromium mesoporphyrinIBA 01/2014 - 11/2008
5	BilirubinIBA 01/2014 - 03/2009
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2014 - 04/2009
4	OsteopontinIBA 01/2015 - 01/2013
4	CytokinesIBA 07/2014 - 01/2010
4	Biliverdine (Biliverdin)IBA 01/2014 - 03/2009
4	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 05/2013 - 11/2008
4	8-epi-prostaglandin F2alphaIBA 05/2013 - 07/2009
3	Extracellular Matrix ProteinsIBA 07/2015 - 11/2008
3	IonsIBA 07/2015 - 01/2014
3	arginine methyl esterIBA 07/2015 - 07/2014
3	NG-Nitroarginine Methyl Ester (L-NAME)IBA 07/2015 - 07/2014
3	nephrinIBA 07/2015 - 01/2014
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2015 - 07/2009
3	EnzymesIBA 01/2015 - 09/2009
3	Interleukin-6 (Interleukin 6)IBA 01/2014 - 01/2013
3	stannous mesoporphyrinIBA 05/2013 - 01/2013
3	MineralocorticoidsIBA 07/2010 - 03/2009
3	Transcription Factors (Transcription Factor)IBA 01/2010 - 11/2008
2	podocalyxinIBA 07/2015 - 01/2014
2	NPHS2 proteinIBA 07/2015 - 01/2014
2	Streptozocin (Streptozotocin)FDA Link 01/2015 - 04/2009
2	beta CateninIBA 01/2015 - 01/2014
2	ChemokinesIBA 07/2014 - 09/2013
2	OsteoprotegerinIBA 07/2014 - 01/2013
2	CholesterolIBA 09/2013 - 01/2013
2	Triglycerides (Triacylglycerol)IBA 09/2013 - 01/2013
2	Chemotactic FactorsIBA 09/2013 - 01/2013
2	JNK Mitogen-Activated Protein KinasesIBA 05/2013 - 01/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013 - 01/2010
2	Endothelins (Endothelin)IBA 05/2013 - 12/2012
2	InterleukinsIBA 05/2013 - 01/2010
2	AMP-Activated Protein KinasesIBA 02/2010 - 05/2009
2	Type C PhospholipasesIBA 09/2009 - 06/2008
2	Phosphotransferases (Kinase)IBA 07/2009 - 11/2008
1	AlbuminsIBA 01/2018
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2018
1	ElementsIBA 01/2017
1	LipidsIBA 12/2016
1	CD2-associated proteinIBA 07/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Glycerol (Glycerine)FDA LinkGeneric 01/2015
1	biliverdin reductaseIBA 01/2014
1	nitrilaseIBA 01/2014
1	Interleukin-10 (Interleukin 10)IBA 01/2014
1	Betaine-Homocysteine S-Methyltransferase (Betaine Homocysteine Methyltransferase)IBA 01/2014
1	Cytoskeletal ProteinsIBA 01/2014

Therapy/Procedure

9	Therapeutics 07/2014 - 11/2008